Mobile app for treatment of stress urinary incontinence: A randomized controlled trial
| Autor: | Eva Samuelsson, Emma Nyström, Ina Asklund, Göran Umefjord, Hans Stenlund, Malin Sjöström |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Adult
self-management medicine.medical_specialty Urology Urinary Incontinence Stress 030232 urology & nephrology Urinary incontinence law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Surveys and Questionnaires Urologi och njurmedicin medicine Urology and Nephrology Humans Aged Sweden 030219 obstetrics & reproductive medicine Self-management business.industry Mobile apps pelvic floor muscle training Pelvic Floor Middle Aged stress urinary incontinence Mobile Applications mobile applications Exercise Therapy Treatment Outcome randomized controlled trial Physical therapy Quality of Life Female Neurology (clinical) medicine.symptom business |
| Zdroj: | Neurourology and urodynamics. 36(5) |
| ISSN: | 1520-6777 |
| Popis: | AIMS: To evaluate the effect of a mobile app treatment for stress urinary incontinence (SUI) in women. METHODS: Randomized controlled trial, conducted 2013-2014 in Sweden. Community-dwelling adult women with ≥1 SUI episode/week recruited through our website and randomized to app treatment (n = 62) or control group (postponed treatment, n = 61). One participant from each group was lost to follow-up. Intervention was the mobile app Tät(®) with a treatment program focused on pelvic floor muscle training (PFMT), and information about SUI and lifestyle factors. Primary outcomes, 3 months after randomization: symptom severity (International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form [ICIQ-UI SF]); and condition-specific quality of life (ICIQ Lower Urinary Tract Symptoms Quality of Life [ICIQ-LUTSqol]). RESULTS: One hundred and twenty-three women were included (mean age 44.7), with moderate/severe SUI (97.5%, 120/123), mean ICIQ-UI SF score 11.1 (SD 2.8) and mean ICIQ-LUTSqol score 34.4 (SD 6.1) at baseline. At follow-up, the app group reported improvements in symptom severity (mean ICIQ-UI SF score reduction: 3.9, 95% confidence interval 3.0-4.7) and condition-specific quality of life (mean ICIQ-LUTSqol score reduction: 4.8, 3.4-6.2) and the groups were significantly different (mean ICIQ-UI SF score difference: -3.2, -4.3to -2.1; mean ICIQ-LUTSqol score difference: -4.6, -7.8 to -1.4). In the app group, 98.4% (60/61) performed PFMT at follow-up, and 41.0% (25/61) performed it daily. CONCLUSIONS: The mobile app treatment was effective for women with SUI and yielded clinically relevant improvements. This app may increase access to first-line treatment and adherence to PFMT. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text